Main navigation
- Programs
- Subjects
- Universities
- Destinations
- Advice
The Ph.D. program focuses on comprehensive interdisciplinary and translational education in Biomedical Sciences, offering specialized training in one of five focused disciplines. Students begin with a shared interdisciplinary foundation year before choosing their specialization from Cancer Biology and Genetics, Infectious Disease and Immunity, Molecular and Cellular Biosciences, Neuroscience, or Organ Systems and Translational Medicine. The program's structure fosters innovative research approaches through interdisciplinary methods, creating fresh avenues for academic exploration. Designed to cultivate top-tier biomedical researchers, the program prepares future leaders in scientific investigation, academia, and public policy. This multidisciplinary Biomedical Sciences graduate curriculum provides five specialization tracks for Ph.D. candidates: Cancer Biology and Genetics, Infectious Disease and Immunity, Molecular and Cellular Biosciences, Neuroscience, and Organ Systems and Translational Medicine
The Cancer Biology and Genetics (CBGN) specialization delivers academic and research experiences focused on oncology and the genetic/molecular foundations of human diseases within Temple University's Lewis Katz School of Medicine Biomedical Sciences Graduate Program. CBGN enables PhD, MD/PhD, and MS students to collaborate with faculty from the Fels Research Institute, Fox Chase Cancer Center (FCCC), and various LKSOM departments. FCCC faculty participation allows students to conduct research in FCCC facilities. Participants can select from multiple research laboratories at both institutions, receiving training in Cancer Biology through studies of cellular transformation, tumor development, signaling pathways, cell cycle regulation, and DNA repair using advanced methodologies. Researchers exploring genetic and epigenetic aspects of health and disease employ cutting-edge genomic technologies. Beyond fundamental research, CBGN scientists are pioneering new therapeutic approaches for cancer treatment and prevention. The program also includes experts in Cancer Prevention, Control, and Immunology.